Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Reports Third Quarter 2021 Financial and Operating Results and Strategic Transactions
November 03, 2021 16:01 ET
|
Rattler Midstream LP
MIDLAND, Texas, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Rattler Midstream LP (NASDAQ: RTLR) (“Rattler” or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today...
OrthoPediatrics Corp. Reports Third Quarter 2021 Financial Results
November 03, 2021 16:01 ET
|
OrthoPediatrics Corp.
WARSAW, Ind., Nov. 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric...
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
November 03, 2021 16:01 ET
|
CRISPR Therapeutics AG
-Achieved target enrollment in CTX001 clinical trials for beta thalassemia (TDT) and sickle cell disease (SCD); regulatory submissions planned for late 2022- -Reported positive results from the...
Altimmune to Announce Third Quarter 2021 Financial Results on November 10, 2021
November 03, 2021 16:01 ET
|
Altimmune, Inc
GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2021 financial...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021 16:01 ET
|
Xenon Pharmaceuticals Inc.
BURNABY, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its third quarter...
MacroGenics to Participate in Upcoming Investor Conferences
November 03, 2021 16:01 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 03, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Recent Corporate Developments
November 03, 2021 16:01 ET
|
Sarepta Therapeutics, Inc.
Net product sales for the third quarter of 2021 reached $166.9 million, a 37% increase over the same quarter of prior yearIn light of its continued over-performance, Sarepta raises its full-year...
Yellow Corporation Reports Third Quarter 2021 Results
November 03, 2021 16:01 ET
|
Yellow Corporation
The Best Operating Ratio Reported in Nearly Three Years OVERLAND PARK, Kan., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Yellow Corporation (NASDAQ: YELL) reported results for the third quarter ended...
S Split Corp. Declares Monthly Distribution
November 03, 2021 16:01 ET
|
S Split Corp.
TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- (TSX: SBN; SBN.PR.A) S Split Corp. has declared monthly distributions, payable on November 30, 2021 to shareholders of record on November 15, 2021. Share...
CUMULUS MEDIA Reports Operating Results for the Third Quarter 2021
November 03, 2021 16:01 ET
|
Cumulus Media Inc.
ATLANTA, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” "CUMULUS MEDIA," “we,” “us,” or “our”) today announced operating results for the nine months ended...
- September 26, 2024 21:32 ET Remee Wire & Cable Appoints John Orona as New Business Development Manager
- September 26, 2024 20:26 ET „LemON Tour” z Cytrynami z Syrakuz PGI przybywa na szczyt G7 ds. Rolnictwa